These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 14626558)

  • 1. [Pharmacologic therapy of acute coronary syndromes].
    Holm F; Aschermann M
    Cas Lek Cesk; 2003 Aug; 142(8):456-9. PubMed ID: 14626558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined antithrombotic therapy for acute coronary syndrome.
    Gawaz M; Müller I; Besta F
    Semin Vasc Med; 2003 May; 3(2):163-76. PubMed ID: 15199479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [How to administer antithrombotic therapy in non-ST-elevation acute coronary syndromes: guidelines and clinical practice].
    Mafrici A
    Ital Heart J; 2005 May; 6 Suppl 3():24S-27S. PubMed ID: 15945316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antithrombotic treatment of acute coronary syndromes.
    Théroux P
    Can J Cardiol; 1998 Aug; 14 Suppl E():6E-10E. PubMed ID: 9779026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of cardiovascular events after acute coronary syndrome.
    Wallentin L
    Semin Vasc Med; 2005 Aug; 5(3):293-300. PubMed ID: 16123917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wall passivation for unstable angina.
    Lettino M; Dailey-Sterling F; Badimon L; Chesebro JH; Badimon JJ
    Semin Interv Cardiol; 1996 Mar; 1(1):60-6. PubMed ID: 9552495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treating patients with acute coronary syndromes with aggressive antiplatelet therapy (from the Global Registry of Acute Coronary Events).
    Lim MJ; Eagle KA; Gore JM; Anderson FA; Dabbous OH; Mehta RH; Granger CB; Fox KA; Spencer FA; Goldberg RJ;
    Am J Cardiol; 2005 Oct; 96(7):917-21. PubMed ID: 16188516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Residual platelet activity is increased in clopidogrel- and ASA-treated patients with coronary stenting for acute coronary syndromes compared with stable coronary artery disease.
    Geisler T; Kapp M; Göhring-Frischholz K; Daub K; Dösch C; Bigalke B; Langer H; Herdeg C; Gawaz M
    Heart; 2008 Jun; 94(6):743-7. PubMed ID: 17567647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antithrombotic therapy and the transition to the catheterization laboratory in UA/NSTEMI.
    Ferguson JJ; Wilson JM; Diez J
    Minerva Cardioangiol; 2007 Oct; 55(5):529-56. PubMed ID: 17912162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The combination of enoxaparin, glycoprotein IIb/IIIa inhibitors and an early invasive approach among acute coronary syndrome patients.
    Lee DS; Bhatt DL; Moliterno DJ; Peacock WF; Ellis SG; Topol EJ
    J Invasive Cardiol; 2004 Feb; 16(2):46-51. PubMed ID: 14760188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tirofiban optimizes platelet inhibition for immediate percutaneous coronary intervention in high-risk acute coronary syndromes.
    Ivandic BT; Kurz K; Keck F; Staritz P; Lehrke S; Katus HA; Giannitsis E
    Thromb Haemost; 2008 Oct; 100(4):648-54. PubMed ID: 18841288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antiplatelets and anticoagulants in acute coronary syndromes: levels of evidence].
    Páramo JA; García R; Rodríguez P; de Gaona ER
    Rev Med Univ Navarra; 2007; 51(1):23-7. PubMed ID: 17555117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of prasugrel compared with clopidogrel in patients with acute coronary syndromes: design and rationale for the TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet InhibitioN with prasugrel Thrombolysis In Myocardial Infarction 38 (TRITON-TIMI 38).
    Wiviott SD; Antman EM; Gibson CM; Montalescot G; Riesmeyer J; Weerakkody G; Winters KJ; Warmke JW; McCabe CH; Braunwald E;
    Am Heart J; 2006 Oct; 152(4):627-35. PubMed ID: 16996826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of antiplatelet therapy in cardiovascular disease I: Acute coronary syndromes.
    Cavendish JJ; Fugit RV; Safani M
    Curr Med Res Opin; 2004 Nov; 20(11):1839-43. PubMed ID: 15537484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology.
    Alexander KP; Newby LK; Cannon CP; Armstrong PW; Gibler WB; Rich MW; Van de Werf F; White HD; Weaver WD; Naylor MD; Gore JM; Krumholz HM; Ohman EM; ;
    Circulation; 2007 May; 115(19):2549-69. PubMed ID: 17502590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The acute coronary ischemic syndromes--the central role of thrombosis.
    Cairns JA
    Can J Cardiol; 1996 Oct; 12(10):901-7. PubMed ID: 9191478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term subcutaneous and oral anticoagulants after acute coronary syndromes.
    Verheugt FW
    Rev Port Cardiol; 2003; 22(7-8):1011-5. PubMed ID: 14587169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. API expert consensus document on management of ischemic heart disease.
    Association of Physicians of India
    J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potent low dose platelet inhibitory effects of clopidogrel and aspirin on coronary thrombus formation in an animal model of acute unstable angina.
    Bierbach B; Horstick G; Berg O; Heimann A; Münzel T; Vahl CF; Kempski O; Darius H
    Thromb Haemost; 2006 Feb; 95(2):354-61. PubMed ID: 16502561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy and safety of prasugrel with and without a glycoprotein IIb/IIIa inhibitor in patients with acute coronary syndromes undergoing percutaneous intervention: a TRITON-TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis In Myocardial Infarction 38) analysis.
    O'Donoghue M; Antman EM; Braunwald E; Murphy SA; Steg PG; Finkelstein A; Penny WF; Fridrich V; McCabe CH; Sabatine MS; Wiviott SD
    J Am Coll Cardiol; 2009 Aug; 54(8):678-85. PubMed ID: 19679245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.